Market Overview:
The global intra-uterine contraceptive devices market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing awareness about contraception, rising prevalence of unintended pregnancies, and technological advancements in intra-uterine contraceptive devices. Based on type, the global intra-uterine contraceptive devices market is segmented into copper IUCD and hormonal IUCD. The copper IUCD segment is expected to account for a larger share of the global market than the hormonal IUCD segment during the forecast period. This can be attributed to factors such as lower cost and longer lifespan of copper IUDs as compared with hormonal IUDs. Based on application, the global intra-uterine contraceptive devices market is divided into hospitals, gynaecology clinics, and community healthcare settings.
Product Definition:
Intra-uterine contraceptive devices (IUCDs) are small, T-shaped objects that are inserted into the uterus in order to prevent pregnancy. IUCDs work by preventing the sperm from fertilizing an egg, and they can also be used to treat heavy menstrual bleeding. IUCDs are one of the most effective forms of contraception available, and they can be used for up to 10 years.
Copper IUCD:
Intrauterine contraceptive devices (IUDs) are a family of small, flexible, hollow metallic objects that are placed in the uterus to prevent pregnancy. There are two types of IUDs available in the market: hormonal and non-hormonal. Copper Intrauterine Contraceptive Device (ICD) is one such example among many others. It is a modern birth control method that has been used for over 40 years and was first approved by the U.
Hormonal IUCD:
Hormonal IUDs are also known as intra-uterine contraceptive devices. They are small silicon or plastic devices that are inserted into the uterus and prevent pregnancy by releasing hormones. Hormonal IUDs can last for three to five years, depending upon how often they need to be replaced. There are two types of hormonal IUDs available in the market namely progesterone-releasing device (Pill) and estrogen-releasing device (Estrace).
Application Insights:
Based on application, the global intra-uterine contraceptive devices market is segmented into hospitals, gynaecology clinics and community healthcare. Hospitals held the largest share in 2017 owing to factors such as a high prevalence of infertility and an increasing number of childbirths that require surgical intervention. According to WHO, approximately 15 million women are estimated to be infertile due to tubal blockage or scarring from previous trauma or surgery resulting in failure of conception. Furthermore, an increase in the number of gynecology surgeries has also led obstetrics units at hospitals to use IUDs for birth control as they are more effective than other methods such as oral contraceptives.
Gynaecology clinics held a significant share owing to their accessibility and convenience coupled with low cost compared with hospital delivery rooms.
Regional Analysis:
Europe dominated the global market in 2017 owing to high prevalence of PCOS and other associated disorders, rising awareness about contraceptives, and availability of a wide range of contraceptive products. Moreover, increasing government initiatives for promoting intrauterine contraception is expected to drive the regional market over the forecast period. For instance, in February 2016 Health Innovation Programme (HIP) launched a new initiative named “Healthy Uterine Contraceptive Devices†which focuses on development of innovative IUDs that do not cause any harm to women's bodies.
Asia Pacific region is anticipated to witness lucrative growth during the forecast period due to growing population and rising incidence rate of unplanned pregnancies especially in developing economies such as India and China.
Growth Factors:
- Increasing awareness about contraception and intra-uterine contraceptive devices (IUDs) among women of childbearing age
- Growing number of product launches and technological advancements in the IUDs market
- Rising prevalence of sexually transmitted infections (STIs) and other gynecological disorders that can be treated with IUDs
- Increasing demand for long-term reversible contraception methods, especially from developed countries
- Steady growth in healthcare spending, particularly in developed countries, which is likely to boost adoption of IUDs
Scope Of The Report
Report Attributes
Report Details
Report Title
Intra-Uterine Contraceptive Devices Market Research Report
By Type
Copper IUCD, Hormonal IUCD
By Application
Hospitals, Gynaecology clinics, Community healthcare
By Companies
Bayer AG, Teva Pharmaceuticals Industries, Mona Lisa N.V., DKT International, Egemen International, Melbea AG, Ocon Medical Ltd., Pregna International Limited, Medical Engineering Corporation SA, SMB Corporation and Meril Life Sciences Pvt. Ltd., Medu Scientific Ltd, China RH Contraceptives Co., Ltd, Sanghai Jolly Medical Education Co., Ltd, Bernstein Leibhard LLP, Zheijang Daji Medical Instruments, Ltd., Nimble International, AME Line, Technico, Cepeo, Contraceptivos, Injeflex Ind And Com Ltda, Bersil, Amed
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
238
Number of Tables & Figures
167
Customization Available
Yes, the report can be customized as per your need.
Global Intra-Uterine Contraceptive Devices Market Report Segments:
The global Intra-Uterine Contraceptive Devices market is segmented on the basis of:
Types
Copper IUCD, Hormonal IUCD
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Gynaecology clinics, Community healthcare
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bayer AG
- Teva Pharmaceuticals Industries
- Mona Lisa N.V.
- DKT International
- Egemen International
- Melbea AG
- Ocon Medical Ltd.
- Pregna International Limited
- Medical Engineering Corporation SA
- SMB Corporation and Meril Life Sciences Pvt. Ltd.
- Medu Scientific Ltd, China RH Contraceptives Co., Ltd
- Sanghai Jolly Medical Education Co., Ltd
- Bernstein Leibhard LLP
- Zheijang Daji Medical Instruments, Ltd.
- Nimble International
- AME Line, Technico
- Cepeo
- Contraceptivos
- Injeflex Ind And Com Ltda
- Bersil
- Amed
Highlights of The Intra-Uterine Contraceptive Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Copper IUCD
- Hormonal IUCD
- By Application:
- Hospitals
- Gynaecology clinics
- Community healthcare
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Intra-Uterine Contraceptive Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Intra-uterine contraceptive devices (IUDs) are a type of birth control that are inserted into the uterus by a doctor. IUDs work by preventing sperm from reaching the egg.
Some of the key players operating in the intra-uterine contraceptive devices market are Bayer AG, Teva Pharmaceuticals Industries, Mona Lisa N.V., DKT International, Egemen International, Melbea AG, Ocon Medical Ltd., Pregna International Limited, Medical Engineering Corporation SA, SMB Corporation and Meril Life Sciences Pvt. Ltd., Medu Scientific Ltd, China RH Contraceptives Co., Ltd, Sanghai Jolly Medical Education Co., Ltd, Bernstein Leibhard LLP, Zheijang Daji Medical Instruments, Ltd., Nimble International, AME Line, Technico, Cepeo, Contraceptivos, Injeflex Ind And Com Ltda, Bersil, Amed.
The intra-uterine contraceptive devices market is expected to register a CAGR of 5.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Intra-Uterine Contraceptive Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Intra-Uterine Contraceptive Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Intra-Uterine Contraceptive Devices Market - Supply Chain
4.5. Global Intra-Uterine Contraceptive Devices Market Forecast
4.5.1. Intra-Uterine Contraceptive Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Intra-Uterine Contraceptive Devices Market Size (000 Units) and Y-o-Y Growth
4.5.3. Intra-Uterine Contraceptive Devices Market Absolute $ Opportunity
5. Global Intra-Uterine Contraceptive Devices Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Intra-Uterine Contraceptive Devices Market Size and Volume Forecast by Type
5.3.1. Copper IUCD
5.3.2. Hormonal IUCD
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Intra-Uterine Contraceptive Devices Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Intra-Uterine Contraceptive Devices Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Gynaecology clinics
6.3.3. Community healthcare
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Intra-Uterine Contraceptive Devices Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Intra-Uterine Contraceptive Devices Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Intra-Uterine Contraceptive Devices Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Intra-Uterine Contraceptive Devices Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Intra-Uterine Contraceptive Devices Demand Share Forecast, 2019-2026
9. North America Intra-Uterine Contraceptive Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Intra-Uterine Contraceptive Devices Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Intra-Uterine Contraceptive Devices Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Gynaecology clinics
9.4.3. Community healthcare
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Intra-Uterine Contraceptive Devices Market Size and Volume Forecast by Type
9.7.1. Copper IUCD
9.7.2. Hormonal IUCD
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Intra-Uterine Contraceptive Devices Demand Share Forecast, 2019-2026
10. Latin America Intra-Uterine Contraceptive Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Intra-Uterine Contraceptive Devices Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Intra-Uterine Contraceptive Devices Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Gynaecology clinics
10.4.3. Community healthcare
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Intra-Uterine Contraceptive Devices Market Size and Volume Forecast by Type
10.7.1. Copper IUCD
10.7.2. Hormonal IUCD
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Intra-Uterine Contraceptive Devices Demand Share Forecast, 2019-2026
11. Europe Intra-Uterine Contraceptive Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Intra-Uterine Contraceptive Devices Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Intra-Uterine Contraceptive Devices Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Gynaecology clinics
11.4.3. Community healthcare
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Intra-Uterine Contraceptive Devices Market Size and Volume Forecast by Type
11.7.1. Copper IUCD
11.7.2. Hormonal IUCD
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.0. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Intra-Uterine Contraceptive Devices Demand Share, 2019-2026
12. Asia Pacific Intra-Uterine Contraceptive Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Intra-Uterine Contraceptive Devices Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Intra-Uterine Contraceptive Devices Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Gynaecology clinics
12.4.3. Community healthcare
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Intra-Uterine Contraceptive Devices Market Size and Volume Forecast by Type
12.7.1. Copper IUCD
12.7.2. Hormonal IUCD
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Intra-Uterine Contraceptive Devices Demand Share, 2019-2026
13. Middle East & Africa Intra-Uterine Contraceptive Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Intra-Uterine Contraceptive Devices Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Intra-Uterine Contraceptive Devices Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Gynaecology clinics
13.4.3. Community healthcare
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Intra-Uterine Contraceptive Devices Market Size and Volume Forecast by Type
13.7.1. Copper IUCD
13.7.2. Hormonal IUCD
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Intra-Uterine Contraceptive Devices Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Intra-Uterine Contraceptive Devices Market: Market Share Analysis
14.2. Intra-Uterine Contraceptive Devices Distributors and Customers
14.3. Intra-Uterine Contraceptive Devices Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Bayer AG
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Teva Pharmaceuticals Industries
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Mona Lisa N.V.
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. DKT International
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Egemen International
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Melbea AG
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Ocon Medical Ltd.
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Pregna International Limited
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Medical Engineering Corporation SA
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. SMB Corporation and Meril Life Sciences Pvt. Ltd.
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Medu Scientific Ltd, China RH Contraceptives Co., Ltd
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Sanghai Jolly Medical Education Co., Ltd
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Bernstein Leibhard LLP
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Zheijang Daji Medical Instruments, Ltd.
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Nimble International
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. AME Line, Technico
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. Cepeo
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. Contraceptivos
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. Injeflex Ind And Com Ltda
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. Bersil
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook